A Functional Vesicular Monoamine Transporter 1 (VMAT1) Gene Variant Is Associated with Affect and the Prevalence of Anxiety, Affective, and Alcohol Use Disorders in a Longitudinal Population-Representative Birth Cohort Study
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Inter-individual differences in the monoaminergic systems have been shown to moderate the risk for a lifetime history of anxiety, affective, and alcohol use disorders. A common single nucleotide polymorphism in the vesicular monoamine transporter 1 gene (VMAT1 rs1390938 G/A; Thr136Ile) has been reported as functional in vitro and associated with bipolar disorder and anxiety. We aimed at assessing the association between the VMAT1 genotype, affect, and affect-related psychiatric disorders in a longitudinal population-representative study. METHODS: We used the database of the Estonian Children Personality Behaviour and Health Study (beginning in 1998). Cohorts of initially 9- (recalled at ages 15 and 18 years, n=579) and 15- (recalled at ages 18 and 25 years; n=654) year-old children provided self-reports on impulsivity, anxiety, depressiveness, neuroticism, and alcohol use. In addition, psychiatric assessment based on DSM-IV was carried out in the older cohort at age 25 years. RESULTS: Subjects homozygous for the less prevalent A (136Ile) allele reported lower maladaptive impulsivity, state and trait anxiety, depressiveness, and neuroticism and were less likely to have been diagnosed with an affective, anxiety, and/or alcohol use disorder by young adulthood. While in the younger cohort alcohol use started at younger age, this birth cohort effect was dependent on genotype: only G allele carriers and in particular the GG homozygotes started alcohol use earlier. CONCLUSIONS: VMAT1 rs1390938/Thr136Ile is associated with mood, personality, and alcohol use in the general population. Subjects homozygous for the "hyperfunction" allele (AA; Ile/Ile) appear to be more resilient to these disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hasin, D. S., Stinson, F. S., Ogburn, E., & Grant, B. F. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.7.830 · Cited by 2,908 · cited 1×
“Genotyping was performed on the Applied Biosystems ViiA 7 Real-Time PCR System using TaqMan Pre-Designed SNP Genotyping Assay and Solis BioDyne 5x HOT FIREPol Probe qPCR Mix Plus (ROX).”
Methodde Graaf, R., ten Have, M., van Gool, C., & van Dorsselaer, S. (2012) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-010-0334-8 · Cited by 390
Johnson, R. A., & Gerstein, D. R. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.1.27 · Cited by 155 · cited 1×
“Alcohol consumption has been shown to be subject to birth cohort effects (Johnson and Gerstein, 1998; Rice et al., 2003; Pabst et al., 2010).”
Background
Cited by
Laas, K., Kiive, E., Mäestu, J., Vaht, M., Veidebaum, T., & Harro, J. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.03.045 · Cited by 46
Self-citationStructural mechanisms for VMAT2 inhibition by tetrabenazine
Dalton, M. P., Cheng, M. H., Bahar, I., & Coleman, J. A. (2024) · eLife · doi:10.7554/elife.91973.4 · Cited by 14
Structural mechanisms for VMAT2 inhibition by tetrabenazine
Dalton, M. P., Cheng, M. H., Bahar, I., & Coleman, J. A. (2023) · doi:10.1101/2023.09.05.556211 · Cited by 6
Metadata
- Authors
- Vaht, M., Kiive, E., Veidebaum, T., & Harro, J.
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-02-09
- Volume
- 19
- Issue
- 7
- Pages
- pyw013
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2253129521
- Cited by
- 37
- References
- 3
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.